Professor David RayProfessor of Medicine and Endocrinology
I have an interest in adrenal disorders, and I led development of novel assays for assessment of adrenal activity (salivary cortisol/cortisone), with resulting publications, which has, since 2015, resulted in replacement of urinary free cortisol, and serum cortisol in the routine diagnosis and monitoring of patients with adrenal disease.
I am professor of Medicine and Endocrinology. I have served as General secretary of the Society for Endocrinology 2012-2015, and I served as deputy chair of the MRC clinical research training fellowship panel from 2012-2016.
My work on glucocorticoid safety has changed practice, with one recent paper being cited 129 times Duru et al (2012) EULAR evidence-based recommendations on the management of medium to high dose systemic glucocorticoid therapy in rheumatic diseases. Annals of the Rheumatic Diseases 71, 54-54.